Baeuerle Patrick 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Baeuerle Patrick
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-10+12,100→ 12,100 totalExercise: $31.83Exp: 2030-12-09→ Common Stock (12,100 underlying)
Holdings
- 350,786(indirect: By APAK Solutions GmbH)
Common Stock
Footnotes (2)
- [F1]The reported securities are owned directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- [F2]25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.